₹504.95
▼ -9.57 -1.86%
17 Jul 2026
NSE Listed
ASM 4Bliss GVS Pharma Ltd. (BLISSGVS)
Volume: 1,18,050Avg Vol 1W: 2,97,604.2Avg Vol 1M: 8,74,033.652W Range:₹118₹553
Key Ratios
Checked 20h agoMarket Cap₹5,457 Cr
Current Price₹504.95
Previous Close₹514.52
High / Low (52w)₹553 / ₹118
Volume1,18,050
Avg Vol (1W)2,97,604.2
Avg Vol (1M)8,74,033.6
Stock P/E159.78
Book Value₹112.75
Dividend Yield0.2%
ROE9%
ROA7.1%
Revenue (TTM)₹774 Cr
Revenue Growth5.1%
Profit Margin11.2%
Total Debt₹20 Cr
Shares Outstanding11 Cr
Face Value₹1
EPS (TTM)₹3.22
P/B4.56
Debt / Equity0.09
50 DMA₹445.31
200 DMA₹256.25
Day change-1.86%
SurveillanceASM 4 (as of 2026-07-15)
Price Chart
₹504.95▲ 219.31% · 1Y
2025-07-162026-07-15
20-day avg volume: 8.7L shares
Pros
- Company is almost debt-free.
- Revenue grew 29% YoY.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 160.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹184 Cr | ₹218 Cr | ₹210 Cr | ₹198 Cr | ₹207 Cr | ₹244 Cr | ₹218 Cr | ₹257 Cr |
| EBITDA | ₹32 Cr | ₹40 Cr | ₹38 Cr | ₹25 Cr | ₹69 Cr | ₹44 Cr | ₹45 Cr | ₹47 Cr |
| Net Profit | ₹21 Cr | ₹24 Cr | ₹24 Cr | ₹16 Cr | ₹43 Cr | ₹27 Cr | ₹23 Cr | ₹36 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹841 Cr | ₹936 Cr | ₹728 Cr | ₹597 Cr | ₹779 Cr | ₹769 Cr | ₹799 Cr | ₹846 Cr |
| EBITDA | ₹202 Cr | ₹186 Cr | ₹150 Cr | ₹110 Cr | ₹133 Cr | ₹116 Cr | ₹153 Cr | ₹134 Cr |
| Net Profit | ₹59 Cr | ₹124 Cr | ₹97 Cr | ₹68 Cr | ₹15 Cr | ₹71 Cr | ₹75 Cr | ₹84 Cr |
| EPS | 5.7 | 11.99 | 9.43 | 6.49 | 1.43 | 6.72 | 7.11 | 7.95 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹860 Cr | ₹905 Cr | ₹1,027 Cr | ₹1,077 Cr | ₹1,109 Cr | ₹1,157 Cr | ₹1,212 Cr | ₹1,301 Cr |
| Total Liabilities | ₹312 Cr | ₹245 Cr | ₹277 Cr | ₹249 Cr | ₹262 Cr | ₹239 Cr | ₹209 Cr | ₹209 Cr |
| Equity | ₹548 Cr | ₹660 Cr | ₹750 Cr | ₹828 Cr | ₹846 Cr | ₹917 Cr | ₹1,003 Cr | ₹1,092 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹-12 Cr | ₹85 Cr | ₹93 Cr | ₹169 Cr | ₹79 Cr | ₹138 Cr | ₹145 Cr | ₹181 Cr |
| Investing | ₹-74 Cr | ₹-48 Cr | ₹-47 Cr | ₹-93 Cr | ₹-8 Cr | ₹-83 Cr | ₹-76 Cr | ₹-38 Cr |
| Financing | ₹17 Cr | ₹-6 Cr | ₹-21 Cr | ₹-24 Cr | ₹-25 Cr | ₹-21 Cr | ₹-30 Cr | ₹-89 Cr |
| Free Cash Flow | ₹-12 Cr | ₹85 Cr | ₹93 Cr | ₹169 Cr | ₹79 Cr | ₹138 Cr | ₹145 Cr | ₹181 Cr |
Shareholding
Promoter 35.36% Institutions 15.49% Public 49.15%
Efficiency & Working Capital
ROCE16.5%
Interest Coverage16.8
Dividend Payout—
Debtor Days204 d
Inventory Days59 d
Payable Days41 d
Cash Conversion Cycle222 d
Working Capital Days263 d
Shareholding Details
As of 2026-03-31
Promoter35.4%
FII10.4%
DII5%
Institutions15.5%
Public49.2%
Promoter Pledge0%
No. of Shareholders44,874
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 35.1% | 35.1% | 35% | 35% | 34.9% | 34.8% | 35.1% | 35.3% | 35.4% | 35.4% | 35.4% | 35.4% |
| FIIs | 16.5% | 16.3% | 15.3% | 14.7% | 13.2% | 12.1% | 13.5% | 13.2% | 12.7% | 13.3% | 14.5% | 10.4% |
| DIIs | 6.6% | 6.6% | 6.6% | 6.6% | 6.6% | 6.6% | 6.6% | 6.6% | 6.5% | 6% | 5.8% | 5% |
| Public | 41.7% | 42% | 43.1% | 43.7% | 45.3% | 46.5% | 44.8% | 45% | 45.4% | 45.4% | 44.3% | 49.2% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 42,182 | 43,234 | 40,758 | 45,157 | 44,737 | 52,937 | 49,558 | 49,517 | 46,707 | 44,461 | 43,380 | 44,874 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Narsimha Shibroor Kamath | Shareholding of Promoter and Promoter Group | 30.7% | 3.24 Cr |
| Gulbarga Trading And Investment Private | Public Shareholding | 5.5% | 58,32,000 |
| Arjun Gautam Ashra | Public Shareholding | 4.8% | 50,49,000 |
| Life Insurance Corporation Of India | Public Shareholding | 4.3% | 45,78,091 |
| Gautam Rasiklal Ashra | Public Shareholding | 2.8% | 29,81,571 |
| Arian Investment Limited | Public Shareholding | 2.5% | 25,93,888 |
| Vibha Gagan Sharma | Shareholding of Promoter and Promoter Group | 2.4% | 25,75,000 |
| Shruti Vishal Rao | Shareholding of Promoter and Promoter Group | 2% | 21,10,000 |
| Coeus Global Opportunities Fund | Public Shareholding | 1.8% | 18,59,594 |
| Ark Global Emerging Companies, Lp | Public Shareholding | 1.4% | 14,98,778 |
| Quadrature Trading Vcc - Sub-fund No. 1 | Public Shareholding | 1.2% | 13,01,235 |
| Shailesh Dalmia | Public Shareholding | 1.2% | 12,44,000 |
| Gagan Harsh Sharma | Shareholding of Promoter and Promoter Group | 0.2% | 2,17,123 |
| Ramadas Vasudev Kamath Huf | Shareholding of Promoter and Promoter Group | 0% | 28,988 |
| Punita Sharma | Shareholding of Promoter and Promoter Group | 0% | 24,962 |
| Shibroor Gokuldas Kamath | Shareholding of Promoter and Promoter Group | 0% | 8,000 |
| Ramadas Vasudev Kamath | Shareholding of Promoter and Promoter Group | 0% | 3,200 |
| Geeta Narsimha Kamath | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shibroor Ravidas Kamath | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Vishal Vijay Rao | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shiv Kumar Sharma | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Radha Sharma | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shagun Sharma | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Lalneet Sharma | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Vijay Bhawanishanker Rao | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Ramadas Vasudev Kamath | 0 | 0% | 2026-03-31 |
| Shibroor Gokuldas Kamath | 0 | 0% | 2026-03-31 |
| Punita Sharma | 0 | 0% | 2026-03-31 |
| Ramadas Vasudev Kamath Huf | 0 | 0% | 2026-03-31 |
| Gagan Harsh Sharma | 0 | 0% | 2026-03-31 |
| Shruti Vishal Rao | 0 | 0% | 2026-03-31 |
| Vibha Gagan Sharma | 0 | 0% | 2026-03-31 |
| Narsimha Shibroor Kamath | 0 | 0% | 2026-03-31 |
| Geeta Narsimha Kamath | 0 | 0% | 2026-03-31 |
| Shibroor Ravidas Kamath | 0 | 0% | 2026-03-31 |
| Vishal Vijay Rao | 0 | 0% | 2026-03-31 |
| Shiv Kumar Sharma | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Nandkumar Kashinath Chodankar | Chairman & Independent Directo | 2026 |
| Shilpa Bhatia | Independent Non Executive Women Director | 2026 |
| Shibroor N Kamath | ED / MD / CEO / Promoter | 2026 |
| Vijayanarayanan Mahadevan | Independent Non Exe. Director | 2026 |
| Deepak Rameshchandra Shah | Independent Non Exe. Director | 2026 |
| Aditi Bhatt | Company Secretary | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceuticals | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Outside India | ₹616 Cr | 93.1% |
| Within India | ₹46 Cr | 6.9% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹1 | 15 | 11 | 11 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-08 | Dividend (1/- per share) | Final |
| dividend | 2026-07-08 | ₹1 (100%) | Final |
| dividend | 2026-02-18 | ₹0.5 (50%) | Interim |
| dividend | 2025-07-24 | ₹0.5 (50%) | Final |
| forthcoming | — | Book Closure | AGM |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 190 | 0 | 0 | 9 | 7 | 208 |
| 2026 | 111 | 0 | 0 | 2 | 3 | 117 |
| 2026 | 2 | 0 | 0 | 7 | 5 | 14 |
Insider / Designated-Person Trades
30 recent disclosure(s)
Mrs. Punita SharmaDisposal · 24,962
Mr. Gagan Harsh SharmaDisposal · 2,17,123
Mr. Gagan Harsh SharmaDisposal · 2,17,123
Mrs. Punita SharmaDisposal · 24,962
Mr. Gagan Harsh SharmaAcquisition · 2,123
Mr. Gagan Harsh SharmaAcquisition · 10,000
Substantial Acquisitions (SAST)
10 disclosure(s)
Market18/05/2026 · 24,962
Market25/06/2025 - 27/06/2025 · 34,985
Market23/06/2025 - 24/06/2025 · 32,818
Market09/06/2025 - 10/06/2025 · 48,627
Market22/05/2025 · 4,707
Market20/05/2025 - 21/05/2025 · 78,863
Company Information
Incorporated1984
ChairmanNandkumar Kashinath Chodankar
AuditorKalyaniwalla & Mistry LLP
Investor Email[email protected]; [email protected]
📍 102 Hyde Park Sakivihar Road, Andheri East, Mumbai, Maharashtra, 400072
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search